The Indian Railways was first brought to India by the British Government. Prada Outlet , The first Director of the Islamic Centre was Raja of Mahmudabad. Cheap Oakley Sunglasses , Again, Malone have opted for two captains, one is club captain the other the first XV captain. Miu Miu Outlet , Later Mattel produced the Entrance Great WWE Action Figure line. Mulberry Outlet , Now if you don't feel you can trust your own eyes it is possible to conduct further tests with some easily attainable equipment.. gucci purses , With the perspective that it is not the ownership of the equipment but its use that generates revenues, leasing seems attractive. Paul Smith Outlet , It is calculated by taking the acquisition cost of the asset, subtracting any residual value and dividing this amount by the total useful life. !
 

EBC Board and Administrative Officers

Officers

President

Prof David Nutt

President
Prof David Nutt

ECNP

Prof David Nutt is currently the Edmond J. Safra Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Experimental Medicine at Imperial College London.

He received his undergraduate training in medicine at Cambridge and Guy's Hospital, and continued training in neurology to MRCP.  After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol University, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008 where he leads a similar group with a particular focus on brain imaging especially PET. 

...see more of this biography

Immediate Past President

Mary G Baker, MBE

Immediate Past President
Mary G Baker, MBE

EFNA Past President

Mary G Baker, MBE, is the immediate past President of the European Brain Council, immediate past President of the European Federation of Neurological Associations, Consultant to the World Health Organisation (WHO), Member of EFPIA Advisory Board and Chair of the Working Group on Parkinson’s Disease formed by the WHO in May 1997, and a member of the Commission’s CONNECT Advisory Forum.  Academic appointments include Associate Membership of the Health Services Research Unit, University of Oxford and Visiting Fellow within the London School of Economics (LSE) Health Centre at the LSE

An Honorary Doctorate from the University of Surrey was conferred upon Mary in 2003 in recognition of her work within the world of Parkinson’s disease and an honorary Doctor of Science from Aston University awarded in July 2013.  In 2009 she received the prestigious British Neuroscience Association Award for Outstanding Contribution to British Neuroscience and for Public Service. 

Vice President

Patrice Boyer

Vice President
Patrice Boyer, MD, Ph.D

EPA

Patrice Boyer, MD, Ph.D is currently full professor of clinical neurosciences psychopathology and psychiatry at the University of Paris 7- Denis Diderot(France), professor of psychiatry (geographical) at the University of Ottawa, Ontario, Canada, and professor of post graduate studies in the same University.

On a European and international level Professor Boyer is past president of the European Psychiatric Association (EPA) and the chairman of the ECNP networks Initiative (ENI) coordinating 6 research networks in Europe. Prof. Boyer is member of the EPA board and executive committee since June 2000.

On a national level Prof. Boyer is member of the steering committee for the development of the research in clinical neurosciences in the new INSERM-ITMO institute in France (Institut Thématique des Neurosciences, Psychiatrie). He is co-chairman of the Master and Doctorate curses for neurobiology at the Universities of Paris 5 and Paris 7 (France) and he has been the president of the second edition of the French Congress of Psychiatry in Lyon, France (17-20 November 2010). He is now the general co-secretary for this congress.

...see more of this biography

Pedro Manuel Palma Leal Ortiz de Montellano

Vice President
Pedro Manuel Palma Leal Ortiz de Montellano

GAMIAN EUROPE

Pedro Manuel Palma Leal Ortiz de Montellano is President of Gamian-Europe (Board member of GAMIAN-Europe since 2006, Treasurer since 2010). Board member, Executive Director and Treasurer of ADEB – Associação de apoioaosdoentesdepressivos e bipolares (Association for support of patients with depression and bipolar disease Portugal). Pedro Montellano has a degree in Agronomic Engineering and a Master Degree in Real Estate Management and Valuation. He is rugby coach for a young players’ team.

Secretary General

Gustave Moonen

Secretary General
Gustave Moonen

 

ENS

Gustave Moonen is currently secretary general of the European Neurological Society, www.ensinfo.org. He is professor emeritus of neurology at the University of Liège, Belgium and honorary head of the department of neurology at the centre hospitalier universitaire de Liège. His research interests include developmental neuroscience, neuroimaging and inflammatory diseases of the nervous system. He authored or co-authored 260 papers and 40 book chapters. He is also past-president of the Belgian neurological society.

Treasurer

Alistair Newton

Treasurer
Alistair Newton

Alistair Newton is Executive Director (and Past President) of the European Dystonia Federation, Past Secretary-General of European Federation of Neurological Associations (EFNA) and Treasurer of EBC. He has held positions in a number of British and European organisations involved in patient-related and scientific activities and has led or contributed to many projects which aim to improve the lives of people living with brain disorders.

Special Adviser

Professor Manfred Westphal

Board member and special adviser to EBC
Manfred Westphal

Manfred Westphal is past Secretary of the European Association of Neurosurgical Societies (EANS), Director of the Department of Neurosurgery. He is a member of the Deutschen Gesellschaft für Neurochirurgie (German Neurosurgical Society), the American Association of Neurological Surgeons and the Congress of Neurological Surgeons and currently the chairman of the Committee for Neuro-Oncology of the World Federation of Neurological Surgeons.

Board members

ECNP

Celso Arango, MD, PhD

Board member
Celso Arango

Celso Arango, MD, PhD is a psychiatrist and Associate Professor of Psychiatry at the University of Maryland in Baltimore and Full Professor of Psychiatry at the Universidad Complutense in Madrid. He is also Head of the Child and Adolescent Department of Psychiatry at Hospital General Universitario Gregorio Marañón. Dr. Arango is the Scientific Director of the Spanish Psychiatric Research Network with 25 centers and more than 400 researchers. He is also Coordinator of the Child and Adolescent First-Episode Psychosis Study (CAFEPS) funded by the Spanish Ministry of Health (with eight centers in Spain) and the Child and Adolescent Neuropsychiatry Network funded by the European College of Neuropsychopharmacology (ECNP). He has written more than 240 peerreviewed articles, 6 books, and more than 35 book chapters. Many of his articles and book chapters have focused on the neurobiology of early-onset and first-episode psychoses as well as the safety of psychiatric medications in pediatric patients. In addition, his group has shown how patients with a first psychotic episode experience greater losses of gray matter than expected and a correlation of gray matter loss with antioxidant status. Dr. Arango has participated in more than 62 competitively funded research projects, as Principal Investigator in 46 of them, including projects with international funding (Stanley Foundation, NARSAD, European Commission, etc.) and several clinical drug trials. He is also coordinator of several multicenter projects that assess multiple prognostic factors and treatment in early-onset psychosis, and is currently participating in five EU projects funded by the VII Framework.

EFNA

Audrey Craven

Board member
Audrey Craven

Audrey Craven is the current President of the European Federation of Neurological Associations [EFNA].

She was elected to the EFNA Board as a representative of the European Headache Alliance – an organisation of which she is the founder and current President. In fact, Audrey began her involvement in neurology patient advocacy in 1994 when she founded the Migraine Association of Ireland [MAI].

Nationally, she is the former Chairperson of the Neurological Alliance of Ireland [NAI], where she sat on various Department of Health expert panels to develop Standards of Care, Neurological Strategy, etc. Internationally, she is a former Council Member of the World Headache Alliance [WHA].

...see more of this biography

EFNS

Richard Hughes

Board member
Richard Hughes MD FRCP FMedSci

Richard Hughes is President of the European Federation of Neurological Societies www.efns.org, Emeritus Professor of Neurology at King’s College London and Honorary Professor University College London. He trained at Clare College, Cambridge, Guy’s Hospital and the National Hospital, Queen Square, London. He was Consultant Neurologist at Guy’s Hospital, London, from 1975 until his retirement in 2007. His research interests include the cause and treatment of inflammatory neuropathy, especially Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. He has been the chief investigator of several randomised controlled trials demonstrating the value of immunotherapy for both these diseases. In 1999 Professor Hughes founded the Cochrane Neuromuscular Review Group, remained its Chief Editor until 2008 and still serves on its editorial Board neuromuscular.cochrane.org. He was the President of the international Peripheral Nerve Society and the founding chair of its special interest group the Inflammatory Neuropathy Consortium www.pnsociety.com.

EPA

Professor Cyril Höschl

Board Member
Cyril Höschl

Cyril Höschl is a representative of the European Psychatric Association (EPA), and President of FEAM (Fédération Européenne des Académies de Médecine). Born in Prague, he started his career at the Psychiatric Research Institute (PRI) in Prague. Currently he is a director of Prague Psychiatric Centre and Centre of Neuropsychiatric Studies, and Professor of Psychiatry and Chairman at Charles University in Prague. He is also Professor of Psychiatry at the University of P.J.Safarik in Kosice, Slovakia. His research interests include psychoneuroendocrinology, psychopharmacology and biological psychiatry.

ESR

Paul Parizel

Board member
Paul M. Parizel, MD, PhD

Paul M. Parizel graduated summa cum laude as M.D. from the Faculty of Medicine, University of Antwerp, Belgium, in 1982. He is a board-certified radiologist, and completed fellowships in neuroradiology at Massachusetts General Hospital, Harvard Medical School (Prof. Dr. Juan M. Taveras), and at Hôpital Erasme, University of Brussels (Prof. Dr. Danielle Balériaux). He developed the neuroradiology division at Antwerp University Hospital.

In 1994, he obtained a Ph.D. degree with a dissertation entitled “The influence of field strength on magnetic resonance imaging  (a comparative study in physicochemical phantoms, isolated brain specimens and clinical applications).” He was able to continue his research thanks to a 3-year ‘Fundamental Clinical Research’ grant from the “Foundation for Scientific Research” in Belgium.

...see more of this biography

FENS

Professor Monica Di Luca

Board member
Monica Di Luca

Monica Di Luca has been professor of Pharmacology  at the University of Milano since 1999.

In 1986 she graduated in Pharmacology and medicinal Chemistry at the University of Milano, in 1992 she discussed her PhD thesis at the University of Milano, and in 1993 she completed a PhD programme in the laboratory of Molecular Biology  of the University of Utrecht, The Netherlands.  Her primary research interest in related to brain and synaptic plasticity both in physiological and pathological conditions, with the primary aim to apply her basic findings to the cure of neurodegenerative diseases. She is author of more that 100 scientific publications on peer reviewed journals.

Monica DiLuca is member of Council and Executive committee of several  national and international scientific organization. From 2000 to 2006 she performed as secretary general of Federation of European Neuroscience Societies and form 2005 she is Chair of the Western Europe Chapter of IBRO. She is actually Vice-President of European Brain Council.

Marian Joëls

Board member
Marian Joëls

Marian Joëls, President of FENS, studied biology in Amsterdam and obtained her PhD degree in Utrecht with David de Wied. She held postdoctoral positions at the University of Texas and at the Scripps Institute in La Jolla. Between 1991 and 2009 she worked at the University of Amsterdam. In 2009 she moved to Utrecht where she currently is professor in Neuroscience and director of the Rudolf Magnus Institute. Her scientific work focuses on the effect of stress on the morphology and function of neurons, in health and disease. She published around 200 papers. Since 2002 she is a member of the Royal Netherlands Academy of Arts and Sciences.

GAMIAN EUROPE

Paul Arteel

Board member
Paul Arteel

Paul Arteel is Executive Director of the Global Alliance of Mental Illness Advocacy networks (GAMIAN Europe), (Mental Health) Patients representative at European level in WHO, European Patients Forum, European Platform of Patients Organizations, Science and Industry, European Brain Council, European Federation of Pharmaceutical Industry and Associations, member of stakeholder advisory board of Roamer, a roadmap for Mental Health Research in Europe, Belgian delegate in Council and treasurer of the Comité Européen Droit Éthique et Psychiatrie (CEDEP) and co-founder and treasurer of the Belgian Schizophrenia Ligue. Mr Arteel, a qualified solicitor, is active in the fields of Patients Rights and Advocacy in Mental Health and anti stigma campaigns and image building on mental health.

Industry Delegates

GE Healthcare

Marc Barlow

Marc Barlow

Marc Barlow was born in Wrexham in North Wales. He attended the University of Wolverhampton and graduated with an honors degree in Biological Sciences. After university, in 1983, he joined the pharmaceutical industry as a sales representative. Marc spent a total of 22 years working in the pharmaceutical industry holding a variety of sales and marketing roles including Global Product Director for neurology and cardiovascular products, Director of Strategic Marketing and Business Development and Sales and Marketing Director. Marc joined GE Healthcare in 2005 initially his as Head of Neurology marketing responsible for the development and delivery of cross business strategies for central nervous system conditions and more recently he has been appointed to run the Disease Strategy group in the Global Marketing organization.

Medtronic

Kristina Dziekan

Kristina Dziekan

Kristina Dziekan is Senior Global Reimbursement Director at Medtronic, covering Neuromodulation therapies. Prior to joining Medtronic in 2006, Kristina worked at GlaxoSmithKline also in a reimbursement and global health outcomes function, both from the UK and Asia. Kristina is a trained Economist who started her career with the Economist Intelligence Unit (EIU) in London and ING Barings in South Africa, conducting economic and political research on sub-Saharan Africa. Kristina holds an MSc in Health Policy, Planning and Financing from the London School of Hygiene and Tropical Medicine and London School of Economics and an MA in International Relations from The Johns Hopkins University/ SAIS.

Servier

Marie-Claire Rettori

Marie-Claire Rettori

Marie-Claire Rettori

After completing a Degree in Pharmacy, a hospital residency, and University Diplomas in Biochemistry and in Medical Pathology, Marie Claire Rettori joined Sevier some 25 years ago.

She spent the first 15 years in the neuropsychiatry department, first as pharmacologist in the preclinical studies of centrally acting agents, then in charge of the development of new drug targets in the neurosciences, such as melatonergic derivatives.

She then moved to the International Training Department to run scientific training sessions for our marketing teams in the subsidiaries around the world, on several Servier drugs in the fields of diabetology, cardiovascular disease, and the neurosciences.

In recent years Marie Claire Rettori has worked in the International Scientific Communications Department of Servier, where she oversees international communications, is in charge of raising awareness of Servier psychotropic drugs, manages Servier’s international grants in the field of psychiatry, and is responsible for relationships with scientific associations.

Administrative Office

Nick Deeming

Executive Director
Nick Deeming

Nick Deeming is Executive Director and joined in April 2013. Nick brings with him a wealth of business and legal experience and he is responsible, working with the President Mary Baker and the Board of EBC, for providing direction to the organisation and developing and implementing its strategy. Nick qualified as a solicitor in the UK and from his early career has worked in business. His mantra is 'finding business solutions without complexity'. He has significant leadership and management experience and has developed international multidisciplinary legal and commercial teams with a focus on harnessing the strength of different cultures. He has specialised in corporate governance of publicly and private owned companies and non-profit board management and he has, through-out his career, been involved in major projects from international litigation, business restructuring to implementing change management and business development projects. 

He is particularly interested in the work and aims of the EBC. He is currently deputy chairman of Worth School, a co-educational Benedictine school with 600 pupils in the South East of England.   

Peter Andersen

Interim CEO
Peter Andersen

Dr. P.H. Andersen was appointed CEO of the European Brain Council as of March 1st, 2014, Previously, he was employed in Lundbeck, a CNS focused Pharmaceutical Company headquartered in Copenhagen, and has worked as SVP of Global Public Affairs and Corporate Patent and Trademarks, as EVP and Head of Research and Corporate Patents and Trademarks at Lundbeck A/S,

Prior to joining Lundbeck, he was CEO and Director of Drug Discovery in Acadia Pharmaceuticals, and prior to that he held various positions at Novo Nordisk from 1983-1997, latest as Corporate Project Director.

Dr. Andersen has been involved in startup of a number of biotechs in Medicon Valley over the years. Currently, he is Chairman of the Board of Directors in Prexton Therapeutics, member of the Board of Directors of to-BBB and member of the Danish Council for Research and Innovation Policy. Previously, he was Chairman of the Board at the Biotech Research & Innovation Centre in Copenhagen, Epitherapeutics Aps, the Research Directory Group in EFPIA and member of the IMI Governing Board and the Policy Group of Research and Education in the Danish Industry Association.

Dr. Andersen holds degrees in Chemistry, Biochemistry and Medicine from University of Copenhagen.

Evelyn Sipido

Office Manager
Eveline Sipido

Eveline Sipido is Office Manager for the EBC and Liaison Officer for EFNS, a position which involves close contact with European and other international scientific societies, as well as government institutions and the EC. She is a former Project Coordinator of EFNA. Eveline Sipido is based in the Florence office of the EFNS.

Tadeusz Hawrot

Senior Public Affairs Manager
Tadeusz Hawrot

Tadeusz Hawrot is Senior Public Affairs Manager for the European Brain Council. He is responsible for encouraging the development of National Action Groups, as well as National Brain Councils. He is responsible for the national and international dissemination of EBC studies and projects. He also plays a major role in coordination between European institutions and the EBC.

Tadeusz Hawrot

Financial Controller
Philippe Heymans

Philippe Heymans joined the Brussels’ EBC team as Financial Controller in August 2013.

He is responsible for budgeting, financial reporting/control and contract management.

One of Philippe’s main objectives is to improve EBC’s reporting methodology and tools.

Associate Members and Observers

Board meetings are also attended by observers from important organisations whose mission is relevant to that of the EBC. Currently the EBC has five observers:

Guy Vingerhoets

Guy Vingerhoets

Guy Vingerhoets represents the Federation of the European Societies of Neuropsychology (ESN). The objects of the federation shall be the furtherance of scientific and professional issues within the field of neuropsychology including cognitive neuropsychology, clinical neuropsychology, behavioural neurology, neuroimaging, and neuropsychological rehabilitation.

Jure Bon

Jure Bon

Jure Bon is the Secretary of the Slovenian Brain Council. He works as a psychiatrist in the Psychiatric Hospital Begunje and in the Division of Neurology, University Medical Centre, Ljubljana. He also serves as Treasurer for the Slovenian Psychiatric Association and is a past member of the Executive board of the Slovenian Neuroscience Association.

Nikolay Gabrovsky

Nikolay Gabrovsky

Nikolay Gabrovsky is neurosurgeon, Head of the Department of Neurosurgery at University Hospital "Pirogov", Sofia, Bulgaria and Vice President of the Bulgarian Society of Neurosurgery. Since 2011 he is National Consultant in Neurosurgery. In 2011 he coordinated the first meeting of the EBC in Bulgaria. Actually he is involved in different scientific projects mainly dedicated to gliomas and biobanking.

No photo available

Kevin Jones represents the European Federation of Associations of Families of People with mental illness (EUFAMI), which was founded in 1992 after a congress, which took place in 1992 in De Haan, Belgium, where carers from all over Europe shared their experiences of helplessness and frustration when living with severe mental illness. They resolved to work together to help both themselves and the people they cared for. EUFAMI is a democratic organisation, registered in Belgium as an international non-profit organisation. EUFAMI have an ongoing commitment to improving care and welfare for people affected by mental illness.

Matilde Leonardi

Matilde Leonardi is the EBC-WHO Liaison Officer. A neurologist, paediatrician and child neurologist, she works at the Italian National Neurological Institute (INN) Besta in Milan, where she leads the Neurology, Public Health and Disability Unit. She is responsible for all the INN Besta’s liaison activities with the EU. She is Co-chair of the WHO-FIC Implementation Committee. She coordinates several national and EU projects on neurology, health and disability policy. She is Vice President of the Italian Federation of Neurological Patients Associations (FIAN – Federazione Italiana delle Associazioni Neurologiche).

Roland Pochet

Roland Pochet

Roland Pochet is Professor of Cell Biology at the Université Libre de Bruxelles. His scientific fields are Cell Biology and Neurosciences. He has been an EMBO predoctoral fellow and a NATO fellow. One of his achievement is the discovery of a new calcium binding protein. He is the General Secretary of the European Calcium Society and of the Belgian Brain Council. His research interest include calcium signalling and cell therapy using neural stem cell and a rat model for Amyotrophic Lateral Sclerosis. He aims to promote Science in a higher standard in terms of European value.